Skip to main content
Log in

Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis

  • Review Article
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose

Atrial high-rate episodes (AHREs) recorded with cardiac implantable electronic devices (CIEDs) have been associated with the development of clinical atrial fibrillation (AF) and increase in stroke and death risk. We sought to perform a systematic review with a meta-analysis to evaluate the prevalence of AHREs detected by CIEDs, their association with stroke risk, development of clinical AF, and mortality among patients without a documented history of AF.

Methods

We searched several databases, ClinicalTrials.gov, references of reviews, and meeting abstract books without any language restrictions up to 9 September 2020. We studied patients with CIEDs in whom AHREs were detected. Exclusion criterion was AF history. Our primary outcome was the risk of ischemic stroke in patients with AHREs.

Results

We deemed eligible eight studies for the meta-analysis enrolling a total of 4322 patients with CIED and without a documented AF history. The overall AHRE incidence ratio was estimated to be 17.56 (95% CI, 8.61 to 35.79) cases per 100 person-years. Evidence of moderate certainty suggests that patients with documented AHREs were 4.45 times (95% CI 2.87–6.91) more likely to develop clinical AF. Evidence of low confidence suggests that AHREs were associated with a 1.90-fold increased stroke risk (95% CI 1.19–3.05). AHREs were not associated with a statistically significant increased mortality risk.

Conclusion

The present systematic review and meta-analysis demonstrated that among patients without a documented history of AF, the detection of AHREs by CIEDs was associated with significant increased risk of clinical AF and stroke.

Registration Number (DOI)

Available in https://doi.org/10.17605/OSF.IO/ZRF6M.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

The data underlying this article are available in the article and in its online supplementary material, and its protocol can be found in https://doi.org/10.17605/OSF.IO/ZRF6M.

Code Availability

Not applicable.

Abbreviations

AF:

Atrial fibrillation

AHREs:

Atrial high-rate episodes

CIED:

Cardiac implantable electronic devices

CIs:

95% Confidence intervals

GRADE:

Grading of Recommendations, Assessment, Development and Evaluations

ICD:

Implantable cardioverter defibrillators

ICM:

Implantable cardiac monitors

NOS:

Newcastle-Ottawa Scale

OR:

Odds ratios

OAC:

Oral anticoagulant

PRISMA:

Preferred Reporting Items for Systematic reviews and Meta-Analysis

RCTs:

Randomized control trials

RoB:

Risk of bias

TIA:

Transient ischemic attack

References

  1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.

    Article  Google Scholar 

  2. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–7.

    Article  Google Scholar 

  3. Gonzalez M, Keating RJ, Markowitz SM, et al. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers. Heart Rhythm. 2014;11(12):2214–21.

    Article  Google Scholar 

  4. Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy. Heart Rhythm. 2015;12(12):2368–75.

    Article  Google Scholar 

  5. Bertaglia E, Blank B, Blomstrom-Lundqvist C, et al. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. Europace. 2019;21(10):1459–67.

    Article  Google Scholar 

  6. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–9.

    Article  CAS  Google Scholar 

  7. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373–498.

    Article  Google Scholar 

  8. Kirchhof P, Blank BF, Calvert M, et al. Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017;190:12–8.

    Article  CAS  Google Scholar 

  9. Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017;189:137–45.

    Article  Google Scholar 

  10. Mahajan R, Perera T, Elliott AD, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018;39(16):1407–15.

    Article  Google Scholar 

  11. Khan AA, Boriani G, Lip GYH. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clin Res Cardiol. 2020;109(4):409–16.

    Article  CAS  Google Scholar 

  12. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

    Article  Google Scholar 

  13. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001;32(2):392–8.

    Article  CAS  Google Scholar 

  14. Cook DA, Reed DA. Appraising the quality of medical education research methods: the medical education research study quality instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015;90(8):1067–76.

    Article  Google Scholar 

  15. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.

    Article  Google Scholar 

  16. Schwarzer G. Meta: an R package for meta-analysis. R News. 2007;7:40–5.

  17. Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–67.

    Article  Google Scholar 

  18. Julious SA. Two-sided confidence intervals for the single proportion: comparison of seven methods by Robert G. Newcombe, Statistics in Medicine 1998;17:857–872. Stat Med. 2005;24(21):3383–4.

  19. Schwarzer G, Chemaitelly H, Abu-Raddad LJ, Rücker G. Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods. 2019;10(3):476–83.

    Article  Google Scholar 

  20. Li YG, Miyazawa K, Pastori D, Szekely O, Shahid F, Lip GYH. Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: the West Birmingham Atrial Fibrillation Project. Int J Cardiol. 2019;292:126–30.

    Article  Google Scholar 

  21. Benezet-Mazuecos J, Iglesias JA, Cortés M, et al. Silent atrial fibrillation in pacemaker early post-implantation period: an unintentionally provoked situation? Europace. 2018;20(5):758–63.

    Article  Google Scholar 

  22. Marinheiro R, Parreira L, Amador P, et al. Clinical impact of oral anticoagulation in patients with atrial high-rate episodes. J Stroke Cerebrovasc Dis. 2019;28(4):971–9.

    Article  Google Scholar 

  23. Nishinarita R, Niwano S, Fukaya H, et al. Burden of implanted-device-detected atrial high-rate episode is associated with future heart failure events- clinical significance of asymptomatic atrial fibrillation in patients with implantable cardiac electronic devices. Circ J. 2019;83(4):736–42.

    Article  CAS  Google Scholar 

  24. O’Neill J, Jegodzinski L, Tayebjee MH. Incidence of subclinical atrial fibrillation in a South Asian population. Pacing Clin Electrophysiol. 2018;41(12):1600–5.

    Article  Google Scholar 

  25. Camm AJ, Simantirakis E, Goette A, et al. Atrial high-rate episodes and stroke prevention. Europace. 2017;19(2):169–79.

    Article  Google Scholar 

  26. Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

ID and MG proposed the structure of the paper, critically appraised the paper, and were the major contributors in writing the manuscript. DT, PA, and CKA screened all titles and abstracts and perused full texts for eligible records; PS and KN independently extracted data from eligible studies; SS and SD assessed risk of bias and evaluated the certainty in our estimates using the GRADE approach; IF and EA proposed the statistical analysis; VK, GG, SP, KG, and KT critically appraised the paper and made the final suggestions. All authors read and approved the final manuscript.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Informed Consent

No humans were involved in this study.

Consent for Publication

Not applicable.

Research Involving Human Participants and/or Animals

Not applicable.

Conflict of Interest

The authors declare no competing interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 2319 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doundoulakis, I., Gavriilaki, M., Tsiachris, D. et al. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther 36, 951–958 (2022). https://doi.org/10.1007/s10557-021-07209-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-021-07209-8

Keywords

Navigation